X-BIOTIX THERAPEUTICS, INC.

Profile

Company Names

X-BIOTIX THERAPEUTICS, INC.

Addresses

465 WAVERLY OAKS RD., STE. 414, WALTHAM, MA 02452

465 WAVERLEY OAKS ROAD, SUITE 414, WALTHAM, MA 02452

Phone Numbers

781.419.6945

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$13,391,941.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-11-12 
$4,009,994.00 
$4,009,994.00 
$0.00 
Equity 
1
2018-04-17 
$9,381,947.00 
$9,381,947.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
G. 
BERNHARDT PH.D. 
EXECUTIVE OFFICER
X-BIOTIX THERAPEUTICS, INC.
DAVID 
 
COOK, PH.D. 
DIRECTOR
X-BIOTIX THERAPEUTICS, INC.
STEPHEN 
T. 
ISAACS 
DIRECTOR
ADURO BIOTECH   |  ADURO BIOTECH, INC.   |  X-BIOTIX THERAPEUTICS, INC.
CHRISTOPHER 
D. 
RAY 
DIRECTOR
ADURO BIOTECH   |  X-BIOTIX THERAPEUTICS, INC.
DOMINIC 
 
RYAN 
EXECUTIVE OFFICER
X-BIOTIX THERAPEUTICS, INC.
M. 
DOMINIC 
RYAN PH.D. 
EXECUTIVE OFFICER
X-BIOTIX THERAPEUTICS, INC.
RAMANI 
 
VARANASI 
EXECUTIVE OFFICER, DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.   |  X-BIOTIX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-11-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-12 
2019-06-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-17 
2019-02-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-17 
2018-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#